DUSP26 and neoplasm: DUSP26 dephosphorylates pSer20 and pSer37 in the p53 transactivation domain (TAD) to inhibit the p53 tumor suppressor function and thereby results in the chemoresistance of neuroblastoma cells to doxorubicin-induced apoptosis [23].